IndieBio—the human and planetary health startup program run by global deep-tech venture fund SOSV—is the world’s most active pre-seed investor for scientists, clinicians, and engineers building companies rooted in biology, medicine, and chemistry. Operating full in-house laboratories in San Francisco and New York City, IndieBio invests between USD 275,000 and USD 525,000 per company to take laboratory breakthroughs and computational biomedical platforms from proof-of-concept to institutional seed and Series A rounds.
Is This Opportunity for You?
- Yes, this is for you if:
- You are a researcher, biologist, bioinformatician, physician, pathologist, chemist, or engineer with a technical insight in life sciences, clinical diagnostics, drug discovery, medical devices, or industrial biology that you want to spin out into a commercial company.
- You need both pre-seed capital and physical access to BSL-1/BSL-2 wet-labs and scientific instrumentation to generate validation data without spending millions building your own lab first.
- You can apply from any university, hospital, or research center worldwide—even before formally incorporating a company.
- No, this is not for you if:
- You are seeking an academic grant to fund basic university research that will remain inside an academic lab without commercial spin-out plans.
- You are building general consumer or enterprise software unrelated to biology, medicine, diagnostics, chemistry, or planetary health.
What Does IndieBio’s (SOSV) Investment Package Cover?
Funding
- USD 275,000 to USD 525,000 Initial Seed Investment — Direct pre-seed funding (starting at a baseline of USD 275,000 for ~8% equity and scaling up to USD 525,000+ for therapeutics and R&D-intensive ventures requiring additional experimental capital).
- Free Access to BSL-1 & BSL-2 Wet-Labs and Dry Labs in SF or NYC — Unlimited 4-month residency access to sequencing equipment, microscopy, cell culture, molecular biology benches, analytical chemistry tools, and hardware prototyping labs.
- FDA Regulatory, Patent & University IP Licensing Support — Direct mentorship from regulatory strategists, hospital reimbursement experts, patent attorneys, and advisors who help negotiate exclusive technology licenses from university tech-transfer offices.
- US Visa Support for International Founders — Legal assistance from SOSV enabling international scientific founders to relocate and work at the San Francisco or New York facilities during the program.
Scientific & Technical Areas Funded by the Call
| IndieBio Track | Examples of Fundable Technologies |
|---|---|
| Computational Biology & AI Drug Discovery | AI-guided protein and antibody design, small-molecule discovery platforms, spatial transcriptomics, and predictive clinical toxicity/efficacy models. |
| Clinical Diagnostics, Digital Pathology & Medical Imaging | Liquid biopsy, computational histopathology and image-based diagnostics, point-of-care biosensors, and oncology/neurology patient stratification. |
| Therapeutics, Regenerative Medicine & MedTech Devices | Gene and cell therapies, targeted drug delivery systems, neurotechnology, smart implants, and surgical or laboratory robotics. |
| Industrial Biotech, AgTech & Planetary Health | Synthetic biology for novel biomaterials, industrial enzymes, biological carbon capture, and climate-resilient agriculture. |
Official Requirements & Key Dates
- Team Structure: Teams of at least 2 co-founders (where at least one holds deep scientific or technical domain expertise) are preferred, though exceptional solo scientific founders willing to build a founding team are also considered.
- Geographic Eligibility: Open to applicants from Latin America and any country worldwide.
- Application Deadline (Spring/Summer 2027 Cohort): February 20, 2027 (IndieBio reviews applications on a rolling basis for its biannual cohorts in New York and San Francisco).
How to Apply Step by Step
- Direct Link to the IndieBio Application Portal: indiebio.co/apply
- Submit the Scientific Application at
indiebio.co/apply: Clearly explain the biological, clinical, or computational mechanism behind your technology, what preliminary validation data you have today, and what milestones you aim to achieve over 4 months in the lab. - Clarify Your Intellectual Property (IP) Status: If your research originated in a university or hospital lab, state whether you own it independently or plan to license it (IndieBio regularly assists accepted founders in negotiating founder-friendly licenses with university tech transfer offices).
References
- IndieBio (SOSV) — Apply to the Program — Official application portal for IndieBio’s San Francisco and New York cohorts.
- SOSV Biotech & Deep Tech Investment Thesis — Pre-seed investment terms, follow-on capital structure, and laboratory facilities.



